Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 5, 2000, Pages 1828-1833

  Halhali, Ali ^a   Tovar, Armando R ^a   Torres, Nimbe ^a   Bourges, Hector ^a   Garabedian, Michele ^b   Larrea, Fernando ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS GROWTH; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; MATERNAL BLOOD; PREECLAMPSIA; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM;

ADULT; BIRTH WEIGHT; BLOOD PRESSURE; CALCITRIOL; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; REFERENCE VALUES;

EID: 0034456706     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.5.1828     Document Type: Article

References (59)

1. National high blood pressure education program working group on high blood pressure in pregnancy
2. Current topic: Pre-eclampsia and the placenta
3. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth
4. Insulin-like growth factors and their binding proteins: Biological actions
5. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
6. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation
7. C-Peptide, insulin-like growth factors-I and II, and IGF-binding protein 1 in umbilical cord serum: Correlations with birthweight
8. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth
9. Intrauterine growth retardation at term: Association between anthropometric and endocrine parameters
10. Insulin-like growth factor I in fetal serum obtained by cordocentesis is correlated with intrauterine growth retardation
11. Intrauterine growth retardation: Evidence for the activation of the insulin-like growth factor (IGF)-related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolitic activity by two months of life
12. IGF-I and IGF-binding protein-1 are related to cortisol in human cord serum
13. Growth hormone, insulin-like growth factor-I and insulin-like growth factor binding protein-3 are regulated differentially in small-for-gestational-age and appropriate-for-gestational-age neonates
14. Comparison of somatomedin-C (SMC/IGF-I), human placental lactogen and Doppler velocimetry between appropriate and small-for-gestational-age pregnancies
15. Lower circulating insulin-like growth factor-I and 1,25-dihydroxyvitamin D levels in preeclampsia
16. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia
17. Insulin-like growth factor-I regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity
18. 3 levels in rats
19. Dietary phosphorus and 1,25-dihydroxyxdtamin D metabolism: Influence of insulin-like growth factor I
20. 3
21. Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25-dihydroxyvitamin D by cultured mammalian kidney cells
22. 3 production
23. 3 biosynthesis during low-P diet in adult rats
24. 3 production in healthy man
25. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults
26. Local action of exogenous growth hormone and insulin-like growth factor-I on the dihydroxyvitamin D production in LLC-PK1 cells
27. 3 synthesis by human placenta in culture
28. Abnormal 1,25-dihydroxyvitamin D metabolism in preeclampsia
29. Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia
30. Pathophysiology of hypocalciuria in preeclampsia: Measurement of intestinal calcium absorption
31. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization, and tissue distribution
32. Immunohistochemical localization of insulin-like growth factors (IGFs) and IGF binding proteins-1, -2 and -3 in human placenta and fetal membranes
33. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embrionic cavities in early human pregnancy: Their potential relevance to maternal-embrionic and fetal interactions
34. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: Evidence for IGF-IGFBP interactions at the fetomaternal interface
35. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation
36. Intrauterine growth as estimated from liveborn birth weight data at 24 to 42 weeks of gestation
37. The colorimetric determination of phosphorus
38. A microassay for 1,25-dihydroxyvitamin D not requiriing high performance liquid chromatography: Application to clinical studies
39. The measurement of the vitamin D-binding protein in human serum
40. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum
41. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
42. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
43. Nonparallel changes of growth hormone (GH) and insulin-like growth factor-I, insulin-like growth factor binding protein-3, and GH-binding protein, after craniospinal irradiation and chemotherapy
44. Fetal growth retardation and preeclampsia
45. Growth hormone and the insulin-like growth factor system in myogenesis
46. The free form of insulin-like growth factor I increases in crculation during normal human pregnancy
47. Serum levels and molecular sizes of growth hormone during pregnancy in relation to levels of lactogens, insulin-like growth factor I and insulin-like growth factor binding protein-1
48. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies
49. Insulin-like growth factor binding proteins in sera of pregnant nonhuman primates
50. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma
51. Serum levels of placenta-specific tissue protein 12 (PP12) in pregnancies complicated by pre-eclampsia, diabetes or twins
52. Elevated circulating levels of a decidual protein, placental 12, in preeclampsia
53. Placental proteins 12 and 14 in pre-eclampsia
54. Insulin resistance and preeclampsia
55. Erythrocyte insulin and insulin-like growth factor-I receptor tyrosine kinase activity in hypertension in pregnancy
56. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia
57. Nutritional regulation of insulin-like growth factor-I
58. Hepatic histidase gene expression responds to protein rehabilitation in undernourished growing rats
59. Effect of nutritional rehabilitation of undernourished rats on serum insulin-like growth factor(IGF)-I and IGF-binding proteins